MucosaTec GmbH – the mucus engineering company
Our mission is to enhance the protective properties of the mucus layer with our innovative concept, protecting people from respiratory infections.
Our first product, a broadly effective nasal spray against various influenza viruses, is currently in the preclinical development phase.
History of MucosaTec GmbH
The COVID-19 pandemic has opened humanity’s eyes. There is an urgent need for broadly effective antiviral therapeutics that are immediately available and readily adaptable. For this reason, the Federal Agency for Disruptive Innovation SPRIND (Bundesagentur für Sprunginnovationen) launched the “broad-spectrum antivirals“ challenge in 2021. Competing against 10 other teams, Team MucBoost’s highly innovative idea fought its way through to the final. MucosaTec GmbH was created as a spin-off of this challenge and is now set to bring Team MucBoost’s successful concept to the market – in the form of a broad-spectrum nasal spray against flu viruses.
Company Location
MucosaTec GmbH is spread over two locations with the Head quarter, Formulation and Analytics in Schiffweiler and R&D and Manufacturing in Berlin. This division enables a large cooperation radius and ensures future collaboration between the partners established in MucBoost in industry and academic research.
Our Founders
Dr. Marius Hittinger
CEO
Dr. Anja Himmelstein
Head of production
Prof. Daniel Lauster
CSO
Our Team
Dr. Carina Fendahl
Head of analytics
Thomas Kuhn
Scientist analytics
David Birreck
Scientist production
Silke Benndorf
Office support Berlin
Seray Şahsuvar
PhD student
Prisca Mohr-Bartholome
Administration
Annika Dehne
Quality assurance
Malte-Ole Schneemann
GMP transfer analytics
Dr. Marius Wirth
GMP transfer analytics
Dr. Markus Bardua
Innovation Manager
